PHARMACOR CEFUROXIME cefuroxime 500mg film coated tablet blister pack

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Kjøp det nå

Last ned Preparatomtale (SPC)
24-08-2020

Aktiv ingrediens:

cefuroxime axetil, Quantity: 601.43 mg

Tilgjengelig fra:

Pharmacor Pty Ltd

INN (International Name):

Cefuroxime axetil

Legemiddelform:

Tablet, film coated

Sammensetning:

Excipient Ingredients: crospovidone; calcium stearate; purified water; colloidal anhydrous silica; calcium carbonate; microcrystalline cellulose; sodium lauryl sulfate; croscarmellose sodium; titanium dioxide; hypromellose; propylene glycol; brilliant blue FCF aluminium lake

Administreringsrute:

Oral

Enheter i pakken:

10, 50, 6, 14, 2, 20

Resept typen:

(S4) Prescription Only Medicine

Indikasjoner:

Cefuroxime is indicated for the treatment of the following mild to moderately severe infections in adults caused by sensitive bacteria: Acute upper respiratory infections: otitis media, sinusitis, tonsillitis and pharyngitis. Acute exacerbations of chronic bronchitis, or acute bronchitis. Skin and skin structure infections for example, furunculosis, pyoderma and impetigo. Acute uncomplicated gonococcal urethritis, and cervicitis due to non-penicillinase producing gonococci.

Produkt oppsummering:

Visual Identification: Blue color capsule shaped biconvex film coated tablets with '203' debossed on one side and plain on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorisasjon status:

Licence status A

Autorisasjon dato:

2017-03-27

Informasjon til brukeren

                                PHARMACOR CEFUROXIME
1
Ver 03
PHARMACOR CEFUROXIME
_cefuroxime (as axetil) _
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET?
Please read this leaflet carefully
before you take PHARMACOR
CEFUROXIME tablets.
This leaflet answers some
common
questions
about
PHARMACOR CEFUROXIME
.
It
does
not contain all of the
available
information.
It does not take the place of
talking to your doctor or
pharmacist.
All medicines have risks and
benefits. Your doctor has
weighed the expected benefits of
you taking PHARMACOR
CEFUROXIME against the risks
this medicine could have for you
.
IF YOU HAVE ANY CONCERNS
ABOUT TAKING THIS MEDICINE,
ASK YOUR DOCTOR OR
PHARMACIST.
KEEP THIS LEAFLET WITH THE
MEDICINE.
You may need to read it again.
WHAT PHARMACOR
CEFUROXIME IS USED
FOR
PHARMACOR CEFUROXIME
works by killing bacteria (germs)
that cause infections such as
infections of the:
•
EAR, NOSE AND THROAT
•
LUNGS OR CHEST
•
URINARY TRACT
•
SKIN AND SOFT TISSUES
PHARMACOR CEFUROXIME
is also used to treat sexually
transmitted infections (urethritis
and cervictis)
PHARMACOR
CEFUROXIME
belongs to a group of medicines
called cephalosporin antibiotics.
PHARMACOR CEFUROXIME
is not addictive.
BEFORE YOU TAKE
PHARMACOR
CEFUROXIME TABLETS
_DO NOT TAKE IF_
You must not take
PHARMACOR CEFUROXIME
tablets if:
•
YOU HAVE EVER HAD AN
ALLERGIC REACTION TO
CEFUROXIME, PENICILLIN OR ANY
OF THE INGREDIENTS LISTED
TOWARD THE END OF THIS
LEAFLET. (SEE INGREDIENTS)
•
THE EXPIRY DATE (EXP)
PRINTED ON THE PACK HAS
PASSED.
•
THE PACKAGING IS TORN OR
SHOWS SIGNS OF TAMPERING.
_TELL YOUR DOCTOR IF: _
_ _
YOU MUST TELL YOUR DOCTOR IF:
•
YOU ARE ALLERGIC TO FOODS,
DYES, PRESERVATIVES OR ANY
OTHER MEDICINES.
•
YOU HAVE HAD TO STOP
TAKING ANOTHER MEDICINE
FOR YOUR INFECTION.
•
YOU TEST YOUR URINE FOR
SUGAR. PHARMACOR
CEFUROXIME TABLETS MAY
INTERFERE WITH SOME URINE
TESTS.
•
YOU HAVE KIDNEY PROBLEMS.
•
YOU ARE PREGNANT, THINK
YOU MAY BE PREGNANT OR ARE
BREASTFEEDING.
•
YOU ARE TAKING ANY OTHER
MEDICINES, INCLUDING MEDICINES
YOU BUY WITHOUT A
                                
                                Les hele dokumentet
                                
                            

Preparatomtale

                                PHARMACOR CEFUROXIME
Ver 03
1
AUSTRALIAN PRODUCT INFORMATION -
PHARMACOR CEFUROXIME (CEFUROXIME
(AS AXETIL))
1.
NAME OF THE MEDICINE
Cefuroxime Axetil
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
PHARMACOR CEFUROXIME is available in 2 strengths for oral
administration containing
250 mg and 500 mg cefuroxime axetil.
PHARMACOR
CEFUROXIME
250
mg:
Each
film
coated
tablet
contains
250
mg
cefuroxime (as cefuroxime axetil)
PHARMACOR
CEFUROXIME
500
mg:
Each
film
coated
tablet
contains
500
mg
cefuroxime (as cefuroxime axetil)
For the full list of excipients, see Section 6.1 List of excipients.
3.
PHARMACEUTICAL FORM
Film coated tablets
PHARMACOR CEFUROXIME 250 mg:
Blue color capsule shaped biconvex film coated tablets with '204'
debossed on one side and
plain on the other side.
PHARMACOR CEFUROXIME 500 mg:
Blue color capsule shaped biconvex film coated tablets with '203'
debossed on one side and
plain on the other side.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Cefuroxime is indicated for the treatment of the following mild to
moderately severe
infections in adults caused by sensitive bacteria:
Acute upper respiratory infections: otitis media, sinusitis,
tonsillitis and pharyngitis.
Acute exacerbations of chronic bronchitis, or acute bronchitis.
Skin and skin structure infections for example, furunculosis, pyoderma
and impetigo.
Acute
uncomplicated
gonococcal
urethritis,
and
cervicitis
due
to
non-penicillinase
producing gonococci.
PHARMACOR CEFUROXIME
Ver 03
2
4.2. DOSE AND METHOD OF ADMINISTRATION
DOSAGE
The usual course of therapy with PHARMACOR CEFUROXIME tablets is 5 to
7 days for
treatment of bronchitis, and 7 to 10 days for other infections.
_Adults _
Acute exacerbations of
Chronic bronchitis - 250 mg to 500 mg twice daily
Acute bronchitis - 250 mg to 500 mg twice daily
Uncomplicated gonococcal
urethritis or cervicitis - single dose of 1 g
Other infections - 250 mg twice daily
METHOD OF ADMINISTRATION
Tablets for oral administration.
Cefuroxime axetil should be taken after a light meal for optimum
absorptio
                                
                                Les hele dokumentet